sentences:
QUALITY ASSESSMENT AND COMPARATIVE ANALYSIS ON THE RECOMMENDATIONS OF CURRENT GUIDELINES ON SCREENING AND DIAGNOSIS OF PERIPHERAL ARTERIAL DISEASE; A SYSTEMATIC REVIEW. IntroductionPeripheral Artery Disease (PAD) is a major atherosclerotic disease, and there are several clinical practice guidelines available for it. The paucity of strong evidence is known to give room for variations in recommendations across guidelines with attendant confusion amongst clinicians in clinical practice. This study aims to conduct a quality assessment and comparative analysis on PAD screening and diagnostic recommendations in the management of PAD.

MethodsWe conducted a systematic review of CPGs written after 2010 and on or before 2020. An exhaustive search was conducted through the major medical databases and websites of specialist international organisations of interest and using our inclusion criteria, the appropriate guidelines were extracted. The AGREE-II instrument was used for quality assessment, while the recommendations across screening and diagnosis were extracted and then comparatively analysed.

ResultsWe found nine guidelines that fit our criteria. The guidelines had the lowest scores across the applicability and stakeholder involvement domains. The highest scores were recorded in the Clarity of presentation, Scope and purpose and Editorial independence in order of decreasing magnitude. Also, the trend was the guideline quality scores improved over time. The guidelines were unanimous in offering to screen to  high-risk  patients, although there were some discrepancies in the appropriate age range and unavailability of strong evidence across the guidelines backing this recommendation. The guidelines also showed harmony in adopting the Ankle-Brachial index as the initial diagnostic investigation of choice. However, concerning further diagnostic investigations and imaging, we found several discrepancies among the recommendations in the absence of strong evidence.

ConclusionThough the quality of the guidelines is shown to be improving over time, they display poor scores in the stakeholder involvement and applicability domains, which could be influencing low interest in research that can improve screening and diagnostic recommendations.

STRENGHTS AND LIMITATIONS- This review, unlike previous studies, focused on Peripheral Arterial Diseases(PAD) guidelines written after 2010 and reflects a synthesis of the current state of guideline quality and the most recent recommendations in PAD management regarding screening and diagnosis.
- Complex data has been aggregated, comparatively assessed using thematic analysis and the results presented in concise and straightforward forms using texts, charts and tables to satisfy the needs of all kinds of readers alike from the medical research community to the patients and public reader.
- By utilising rigorous systematic review methodology and a mixed qualitative and quantitative approach to the data analysis, this study has revealed the current areas of strengths and weaknesses of the quality of the PAD guidelines, which is inadvertently related to the reason behind the persisting absence of high-level evidence in screening and diagnostic recommendations.
- Qualitative analyses are inherently challenging to process, especially when dealing with clinical practise guidelines (CPGs) that contain large amounts of information; as such, the process was cumbersome and time-consuming with the inevitable loss of data during the thematic classification process.
- During the literature search, the search strategies were executed exclusively in English Language labouring under the auspices that the major PAD CPGs will have an English language translation, so it is possible that some guidelines written within the study timeframe were not captured due to this limitation.

RegistrationRegistrated in PROSPERO; ID; CRD42020219176

labels: cardiovascular medicine


sentences:
Cross-sectional equity analysis of accessibility by automobile to tertiary care emergency services in Cali, Colombia in 2020 This study provides data on equity in accessibility to tertiary care emergency services in Cali, accounting for traffic congestion, in two separate weeks in 2020.

This cross-sectional study builds on a proof-of-concept, the AMORE Project(1) and provides a baseline assessment of accessibility to urgent tertiary care at peak and free flow traffic times in Cali.1 It makes the case for assessing travel time over distance, and accounting for traffic congestion.

This study indicates that people in vulnerable situations have to travel longer and therefore invest more of their personal direct and indirect resources to access tertiary care emergency departments than the average population. This study emphasizes the added value of integrating new data sources that can inform health services and urban planning. These new data sources merit future testing by concerned stakeholders.1

This study used the digital AMORE Platform to show the effects of traffic congestion on equitable access to tertiary care emergency departments. The data shows which populations take longer to reach a facility within a time threshold under different traffic congestion levels.

The broader proof-of-concept assesses the value of new data obtained by integrating secondary data from publicly available sources. These sources combine geospatial analysis with census microdata, health services location data, and bigdata for travel times.

The analysis covered the city of Cali, which has 2.258 million residents and is the third-largest city in Colombia. The analysis shows the projected accessibility assessments for two weeks during the COVID-19 pandemic, 6 - 12 July 2020, and 23 - 29 November 2020. Restrictions on car travel had been lifted before the July assessment, but stay-at-home orders were in place during the November assessment, which showed substantially less traffic.

This assessment found that traffic congestion sharply reduces accessibility to tertiary emergency care. Reduced access has the greatest impact on people with less education, those living in low-income households or on the periphery of Cali, and specific ethnic groups (e.g., nomadic people like the Rrom, and Afro-descendants). This assessment also identifies the concentration of tertiary care emergency departments in areas of lower population density, leaving large swaths of the population with poor accessibility.

Data was reported in dashboards that used simple univariate and bivariate analyses. In July 2020, the estimated overall accessibility at peak traffic hours was 37% and in November 2020 it increased to 57% due to reduced traffic congestion. These results illustrate the value of the proposed tools in monitoring and adjusting to changing conditions.

labels: health systems and quality improvement


sentences:
A Systems Biology Workflow to Support the Diagnosis of Pyrimidine and Urea Cycle Disorders BackgroundPyrimidine (and purine) metabolism provides essential high-energy vehicles, universal throughout all life, which carry both activated metabolites that serve as fuel and building blocks for countless metabolic processes as well as the messenger molecules that steer these processes. Furthermore, these nitrogen-containing structures encode the alphabet needed to construct the genetic code. The pyrimidine pathway overlaps with the Urea Cycle through a common metabolite (carbamoyl phosphate), with the urea cycle being responsible for the production of several amino acids and removing ammonia. Various Inherited Metabolic Disorders (IMDs) disrupt these pathways, with considerably large phenotypic variation in affected patients, hindering diagnosis. Moreover, the biomarkers for these disorders overlap substantially between the IMDs and their underlying biological pathways, interfering with identifying the deficient protein. We developed a framework that allows us to combine clinical and theoretical biomarkers with pathway models through network approaches and semantic web technologies to support the diagnosis of pyrimidine and urea cycle IMDs.

MethodsWe integrated literature and expert knowledge into machine-readable pathway models for pyrimidine and urea cycle disorders, including disease information and relevant downstream biomarkers. The theoretical change for each biomarker per disease was compiled based on a manual database search. The top three pathways of interest were retrieved through semantic web technologies, by selecting pathways that covered most unique markers as well as showing overlap with the theoretical marker data. These pathways and the corresponding clinical data were visualized through network analysis. Two expert laboratory scientists evaluated our approach by diagnosing a cohort of sixteen previously diagnosed patients with various pyrimidine and urea cycle disorders, based on a visualization of theoretical biomarker overlap with patient data, as well as top three pathways displaying the relationships between the individual biomarkers.

ResultsThe number of relevant biomarkers for each patient varies greatly (five to 48), and likewise the pathways covering most unique biomarkers differ for equivalent disorders. The two experts reached similar conclusions regarding the diagnosis of nine patient samples without knowledge about clinical symptoms or sex. For the remaining seven cases, four interpretations pointed in the direction of a subset of disorders, which could be prioritized for further investigation. Three cases were found to be undiagnosable with the data available.

ConclusionThe presented workflow supports the diagnosis of several IMDs of pyrimidine and urea cycle pathways, by directly linking biological pathway knowledge and theoretical biomarker data to clinical cases. This workflow is adaptable to analyze different types of IMDs, difficult patient cases and functional assays in the future. Furthermore, the pathway models can be used as a basis to perform various other types of (omics) data analysis, e.g. transcriptomics, metabolomics, fluxomics.

Data AvailabilityThe data used in this study have been deposited at https://github.com/BiGCAT-UM/IMD-PUPY.

Highlights- Machine readable pathway models suitable for purine, pyrimidine, and urea cycle omics data analysis
- Visualizing clinically validated biomarkers with pathway knowledge and theoretical biomarker data
- Utilizing semantic web technology and network approaches to precisely represent the biochemistry underlying pyrimidine and urea cycle disorders
- Opens up the possibility to visualize the interactions between metabolic pathways, which can be used in the diagnostic workflow
- Approach is extendable to other inherited metabolic disorders

labels: genetic and genomic medicine


sentences:
Integrating Human Brain Proteomic Data with Genome-Wide Association Study Findings Identifies Novel Brain Proteins in Substance Use Traits BackgroundDespite the growing number of genetic risk loci identified for substance use traits (SUTs), the impact of these loci on protein abundance and their potential as therapeutic targets are unknown.

MethodsTo address this, we performed a proteome-wide association study (PWAS) by integrating human brain proteomes from discovery (Banner; N = 152) and validation (ROSMAP; N = 376) datasets with genome-wide association study (GWAS) summary statistics for 4 SUTs. The sample comprised 4 GWAS of European-ancestry individuals for smoking initiation [Smk] (N = 1,232,091), alcohol use disorder [AUD] (N = 313,959), cannabis use disorder [CUD] (N = 384,032), and opioid use disorder [OUD] (N = 302,585). We conducted transcriptome-wide association studies (TWAS) with human brain transcriptomic data to examine the overlap of genetic effects at the proteomic and transcriptomic levels and tested significant genes for causality through Colocalization analysis.

ResultsTwenty-seven genes (Smk=21, AUD=3, CUD=2, OUD=1) were significantly associated with cis-regulated brain protein abundance. There was evidence for causality in 6 genes (Smk: NT5C2, GMPPB, NQO1, SRR, and ACTR1B; AUD: CTNND1), which act by regulating brain protein abundance. Cis-regulated transcript levels for 8 genes (Smk=6, CUD=1, OUD=1) were associated with SUTs, indicating that genetic loci could confer risk for these SUTs by modulating both gene expression and proteomic abundance.

ConclusionsFunctional studies of the high-confidence risk proteins (SRR for Smk and CTNND1 for AUD) identified here are needed to determine whether they are modifiable targets and useful in developing medications and biomarkers for these SUTs.


sentences: Liability-scale heritability estimation for biobank studies of low prevalence disease Theory for liability-scale models of the underlying genetic basis of complex disease provides an important way to interpret, compare and understand results generated from biological studies. In particular, liability models facilitate an understanding and comparison of the relative importance of genetic and environmental risk factors that shape different clinically important disease outcomes, through estimation of the liability-scale heritability (LSH). Increasingly, large-scale biobank studies that link genetic information to electronic health records are becoming available, containing hundreds of disease diagnosis indicators that mostly occur infrequently within the sample. Here, we propose an extension of the existing liability-scale model theory suitable for estimating LSH in biobank studies of low-prevalence disease. In a simulation study, we find that our derived expression yields lower MSE and is less sensitive to prevalence misspecification as compared to previous transformations, for diseases with [≤] 2% population prevalence and LSH of [≤] 0.45, especially if the biobank sample prevalence is less than that of the wider population. Applying our expression to 13 diagnostic outcomes of [≤] 3% prevalence in the UK Biobank study, revealed important differences in LSH obtained from the different theoretical expressions, that impact the conclusions made when comparing LSH across disease outcomes. This demonstrates the importance of careful consideration for estimation and prediction of low prevalence disease outcomes, and facilitates improved inference of the underlying genetic basis of [≤] 2% population prevalence diseases, especially where biobanking sample ascertainment results in a healthier sample population.


sentences: Artificial intelligence-driven meta-analysis of brain gene expression data identifies novel gene candidates in Alzheimer's Disease Microarrays have identified thousands of dysregulated genes in the brains of patients with Alzheimers disease (AD); yet identifying the best gene candidates to both model and treat AD remains a challenge. To this end, we performed a meta-analysis of microarray data from the frontal cortex and cerebellum of AD patients, followed by an artificial-intelligence driven approach to identify the top AD gene candidates. In the frontal cortex, gene candidates included mitochondrial complex V subunits: ATP5J, ATP5L and ATP5H. In the cerebellum, the top candidate was SC5D, which is involved in cholesterol biosynthesis and catabolism. An important finding was that there was no overlap in dysregulated pathways between the frontal cortex and cerebellum, suggesting that pathophysiological mechanisms in AD are brain-region specific. Combined, these results have significant implications for future models and therapeutic strategies in AD.


sentences:
The HR Challenges: Building Workplace Resilience in the Healthcare Industry During the COVID-19 Pandemic - A Systematic Review The COVID-19 outbreak has wreaked havoc worldwide,disrupting industries and life, posing hitches for stakeholders, organizations, and common people. The viable workplace and smooth living have been challenged and forced the organizations to introduce an innovative, imaginative, and comprehensive approach to respond to the challenges. The companies have been striving hard to adjust to the new normal. At the same time, the government, on the other hand, is trying to normalize the situation for the general public.Industries have maintained their services by implementing a work-from-home strategy. However, forthe healthcare industry, it was not an option. Though telemedicine/consultation was hailed as a solution, but in low-income countries, it was met with skepticism, forcing health personnel to contact patients personally. However, this has jeopardized health workers lives and resulted in a human resource shortage.Nevertheless, the study aimed to identify HR challenges and interventionsto createa resilient workplace.

Nonetheless, following a systematic review from17 databases, the HR challenges and strategic responses for a workable workplace have been highlighted. The results identified are shown in the table enlisting as challenges, manifestation, strategy, and different levels of the interventions. Furthermore, HR professionals devised a plan for the employees to rejuvenate and refresh themselves from stress and weariness by doing meditation yoga sessions that gave physical and mental support.All of these techniques contributed significantly to a stable working environment.


sentences:
SurvMaximin: Robust Federated Approach to Transporting Survival Risk Prediction Models ObjectiveFor multi-center heterogeneous Real-World Data (RWD) with time-to-event outcomes and high-dimensional features, we propose the SurvMaximin algorithm to estimate Cox model feature coefficients for a target population by borrowing summary information from a set of health care centers without sharing patient-level information.

Materials and MethodsFor each of the centers from which we want to borrow information to improve the prediction performance for the target population, a penalized Cox model is fitted to estimate feature coefficients for the center. Using estimated feature coefficients and the covariance matrix of the target population, we then obtain a SurvMaximin estimated set of feature coefficients for the target population. The target population can be an entire cohort comprised of all centers, corresponding to federated learning, or can be a single center, corresponding to transfer learning.

ResultsSimulation studies and a real-world international electronic health records application study, with 15 participating health care centers across three countries (France, Germany, and the U.S.), show that the proposed SurvMaximin algorithm achieves comparable or higher accuracy compared with the estimator using only the information of the target site and other existing methods. The SurvMaximin estimator is robust to variations in sample sizes and estimated feature coefficients between centers, which amounts to significantly improved estimates for target sites with fewer observations.

ConclusionsThe SurvMaximin method is well suited for both federated and transfer learning in the high-dimensional survival analysis setting. SurvMaximin only requires a one-time summary information exchange from participating centers. Estimated regression vectors can be very heterogeneous. SurvMaximin provides robust Cox feature coefficient estimates without outcome information in the target population and is privacy-preserving.

labels: infectious diseases


sentences:
Evaluating the Association and Predictability of Complex Medication Regimen Scores with Clinical Outcomes Among the Critically Ill IntroductionMedication Regimen Complexity (MRC) refers to the combination of medication classes, dosages, and frequencies. The relationship between MRC and clinical outcomes in the intensive care unit (ICU) has not been examined. The objective of this study is to examine the association between MRC scoring tools and their utility in predicting clinical outcomes.

MethodsWe conducted a retrospective cohort study that includes 322 adult patients admitted and stayed (>24 hours) to the ICU between February 1, 2020, and August 30, 2020 in a community-based, teaching hospital in Rhode Island. Medication complexity was assessed using two MRC scoring tools: MRC Index (MRCI) and the MRC in ICU (MRCICU). We used a multivariable logistic regression model to identify the association between MRC scores and clinical outcomes and to predict the clinical outcomes.

RESULTSAmong the 317 patients included in the study (55.2% men with a median age of 62 [IQR: 51-75] years). Higher MRC scores (i.e., > 63 MRCI or > 6 MRCICU) were associated with increased mortality (14% and 15%), longer ICU length of stay (LOS)(30% and 34%), and need for MV (24% and 28%). MRCICU scores at 24 hours were found to be a significant risk factor in all clinical outcomes (ICU mortality, LOS, and MV) with Odds Ratio (ORs) of 1.12 (95% CI: 1.06-1.19), 1.17 (1.1-1.24), and 1.21 (1.14-1.29), respectively. In the prediction models, both MRCI and MRCICU models performed similarly (AUC: 0.88 [0.75-0.97] and 0.88 [0.76-0.97] in predicting mortality. The Medication Model included 15 medication classes outperformed others (AUC: 0.82 [0.71-0.93] in predicting ICU LOS and the MRCICU model outperformed others (AUC: 0.87 [0.77-0.96]) in predicting the need for MV.

CONCLUSIONMRC scores are associated with poorer clinical outcomes and improves the prediction of poorer clinical outcomes which will support clinicians to prescribe safer therapies.

labels: intensive care and critical care medicine


sentences:
A longitudinal investigation of blood neurofilament light chain levels in chronic cocaine users ObjectivesTo explore the hypothesis that plasma levels of neurofilament light chain (NfL), a marker of neuroaxonal pathology, are elevated in chronic cocaine users (CU) and longitudinally associated with changes in cocaine use.

MethodsAs part of the Social Stress Cocaine Study (SSCP), we assessed 35 CU and 35 stimulant-naive healthy controls (HC) at baseline and at a 4-month follow-up. Plasma NfL levels were determined from blood samples using single molecule array (SIMOA) technology. Substance use was subjectively assessed with an extensive interview and objectively measured via toxicological analysis of urine and 4-month hair samples.

ResultsIn a generalized linear model corrected for sex, age, and body mass index, NfL plasma levels were elevated in CU compared to HC (p<0.05). A moderate positive correlation between cocaine hair concentration and NfL levels was also found in CU (r(s)=0.36, p=0.03). Changes in cocaine hair concentration (group analysis of increasers vs. decreasers) over the 4-month interval predicted NfL levels at follow-up (p=0.002), indicating a rise in NfL with increased cocaine use and a reduction with decreased use. No associations between use or change of use of other substances (including the cocaine adulterant levamisole) and NfL levels were found (r(s)[≤]{+/-}0.27, p>0.05).

ConclusionsOur findings demonstrate that NfL is a sensitive marker for assessing cocaine-related brain pathology, supporting the utility of blood NfL analysis in addiction research. The results also suggest that cocaine use should be considered a potential confounder in diagnostic applications and clinical studies using NfL.

labels: addiction medicine


sentences: Identification and Functional Characterization of Bicaudal-D2 As A Candidate Disease Gene in Autosomal Recessive Consanguineous Family with Dilated Cardiomyopathy Familial Dilated cardiomyopathy (DCM) is a genetic cardiomyopathy with reduced left ventricle function or systolic function. Fifty-one DCM genes have been reported, most of which are inherited in an autosomal dominant manner, while those caused by a recessive manner are rarely observed. Here we identified an autosome recessive and evolutionarily conserved missense variant, c.2429G>A: p.Arg810His, in bicaudal D homolog 2 (BICD2), which was segregated with the disease phenotype in a consanguineous family with DCM. Furthermore, we confirmed the presence of BICD2 variants in 3 of 210 sporadic cases, highlighting its candidate causative role. Interestingly, we discovered that BICD2 expressed higher in cardiomyocytes from DCM than that from control by reanalyzing published scRNA-seq dataset, implicating its possible involvement in cardiac function. We next explored BICD2 function in zebrafish model at both embryonic and adult stages. Knockout of bicd2 resulted in partial embryonic lethality in homozygotes, suggesting a vital role for bicd2 in embryogenesis. We performed zebrafish echocardiography to detect indices of ventricular size at the adult zebrafish stage. Intriguingly, dilated hearts, decreased ejection fraction, cardiac output and stroke volume were observed, suggesting a phenotype similar to human DCM in bicd2-knockout homozygotes. Furthermore, RNA-seq confirmed the largest transcriptome shift in bicd2 homozygotes. Gene Set Enrichment Analysis(GSEA) of bicd2-deficient fish showed altered gene expression enriched in cardiac pathways and mitochondrial energy metabolism. In conclusion, we found for the first time that an autosomal recessive BICD2 variant is associated with familial DCM, providing further insight into the molecular pathological mechanism of DCM.


sentences:
RISK STRATIFICATION OF PATIENTS WITH COVID-19 DISEASE THROUGH THE USE OF CLINICAL SCORES IN AN EMERGENCY DEPARTMENT. A review of the literature ObjectiveTo analyze various clinical scores and to understand which of these are able to predict mortality and clinical worsening in patients with Covid-19 disease admitted to an ED.

Material and methodsThe research question was: What are the best clinical scores used to predict hospital mortality or worsening of clinical conditions with hospitalization in intensive care in adult patients with Covid-19 who present in EDa The research of the articles and the consequent review of the literature were performed using databases such as Pubmed, Cochrane Database of Systematic Re-view and CINAHL Database (Cumulative Index to Nursing and Allied Health Literature) until November 4, 2021. The keywords used were clinical scores, risk stratifications, Covid patients and Emergency Department. Inclusion criteria were patients > 18 years with symptoms and diagnosed Covid-19 disease admitted to the ED or directly to the hospital, prospective and retrospective cohort studies, randomized studies, meta-analyses, use or analysis of a clinical score and articles published in English between January 2020 and August 2021 without countries restrictions. Exclusion criteria were unpublished articles, articles without abstracts, articles with a population different from the selected one, articles with outcomes different from those selected and articles that did not mention or did not analyze the effectiveness of a score or a scale. The studies selected compared NEWS, NEWS2, SIRS, q-SOFA, CURB-65, PSI, REMS, MEWS, RISE UP, 4C MORTALITY SCORE, TRPNCLP and STPCAL scores for patients with confirmed Covid-19 disease admitted to Emergency Department. A meta-analysis was carried out by using fixed effects and random effects models to evaluate mortality and Intensive Care Unit (ICU) admission in patients presenting in ED.

ResultsA total of 39318 patients from 8 studies, 5 retrospective observational and 3 prospective, were included. Likelihood ratio was 9.1 (95% CI, 4.76-17.5) for NEWS and 3.3 (95% CI, 2.5-4.3) for NEWS2 in two different studies. The Area Under the Curve values were regarding to intensive care unit admission 0.94 (95% CI, 0.88-0.99) and 0.8 (95% CI, 0.72-0.8) for NEWS and NEWS2 respectively. Considering mortality AUC values were 0.87 (95% CI, 0.72-1.00) and 0.8 (95% CI, 0.72-0.88) for NEWS and NEWS2 respectively. q-SOFA is probably the second most reliable score, analyzed and studied by most of the articles and in one study AUC value was 0.78 (95% CI, 0.60-0.96) for mortality and 0.78 (95% CI, 0.64-0.93) for ICU admission. Considering the scores created and studied specifically for Covid-19 disease the most accurate is the TRPNCLP score with a AUC value of 0.88 (95% CI, 0.85-0.91) and an LR + of 4.86 (95% CI, 4.01 - 5.88). Also RISE UP score and 4C mortality score had excellent results with a positive LR +> 1 and AUC values very close to the 0.80.

ConclusionsThe clinical scores that are more reliable in predicting hospital mortality and admission to intensive care units are NEWS and NEWS2. At the beginning Covid-19 disease management is based on home monitoring so that the use of clinical scores NEWS and NEWS2 could be an effective to predict mortality and worsening of clinical conditions.

labels: emergency medicine


sentences:
Fatality assessment and variant risk monitoring for COVID-19 using three new hospital occupancy related metrics BackgroundThough case fatality rate (CFR) is widely used to reflect COVID-19 fatality risk, its use is limited by large temporal and spatial variation. Hospital mortality rate (HMR) is also used to assess the severity of COVID-19, but HMR data is not directly available except 35 states of USA. Alternative metrics are needed for COVID-19 severity and fatality assessment.

MethodsNew metrics and their applications in fatality measurements and risk monitoring are proposed here. We also introduce a new mathematical model to estimate average hospital length of stay for death (Ldead) and discharges (Ldis). Multiple data sources were used for our analysis.

FindingsWe propose three new metrics, hospital occupancy mortality rate (HOMR), ratio of total deaths to hospital occupancy (TDHOR) and ratio of hospital occupancy to cases (HOCR), for dynamic assessment of COVID-19 fatality risk. Estimated Ldead and Ldis for 501,079 COVID-19 hospitalizations in US 34 states between Aug 7, 2020 and Mar 1, 2021 were 14.0 and 18.2 days, respectively. We found that TDHOR values of 27 countries are less spatially and temporally variable and more capable of detecting changes in COVID-19 fatality risk. The dramatic changes in COVID-19 CFR observed in 27 countries during early stages of the pandemic were mostly caused by undiagnosed cases. Compared to the first week of November, 2021, the week mean HOCRs (mimics hospitalization-to-case ratio) for Omicron variant decreased 34.08% and 65.16% in the United Kingdom and USA respectively as of Jan 16, 2022.

InterpretationThese new and reliable measurements for COVID-19 that could be expanded as a general index to other fatal infectious diseases for disease fatality risk and variant-associated risk monitoring.

Research in contextO_ST_ABSEvidence before this studyC_ST_ABSWe searched PubMed, medRxiv, and bioRxiv for peer-reviewed articles, preprints, and research reports on risk and health care evaluation for COVID-19 using the search terms "hospital occupancy mortality rate", "ratio of total deaths to hospital occupancy", "ratio of hospital occupancy to case" up to Jan 20, 2022. No similar concepts or studies were found. No similar mathematical models based on "hospital occupancy mortality rate" for the estimation of hospital length of stay for deaths and discharges have been identified to date.

Added value of the studyOur new metrics, HOMR and TDHOR, mimic HMR for COVID-19 fatality risk assessment but utilize readily available data for many US states and countries around the world. HOCR mimics hospitalization-to-case ratio for COVID-19. We also provide evidence that explains why COVID-19 CFR has such dramatic changes at the beginning of a COVID-19 outbreak. We have additionally provided new metrics for COVID-19 fatality risk dynamic monitoring including Omicron variant and showed that these metrics provided additional information.

Implications of all the available evidenceThe results of this study, including average hospital length of stay for deaths and discharges for over 500,000 COVID-19 hospitalizations in the US, can aid county, state, and national leaders in making informed public health decisions related to the ongoing COVID-19 pandemic. This is the first study to provide quantitative evidence to address why CFR has a such a large variation at the beginning of the COVID-19 pandemic in most countries and will hopefully encourage more countries to release hospital occupancy data, which we show is both useful and easy information to collect. The new metrics introduced by our study are effective indicators for monitoring COVID-19 fatality risk, as well as potentially fatal COVID-19 variants, and could also be expanded to other fatal infectious diseases.

labels: epidemiology


sentences:
Modeling Vaccinations, Virus Variants and Lockdown: Early guidance for Sars-Cov-2 health policies in India In this paper we consider long range models that help in predicting the impact of virus transmission over a period of a few months. This is applied in the context of the SARS-CoV2 virus for India. Long range models are useful for preemptive policy actions. Our models utilize a dynamic transmission factor, dependent on the populations knowledge and tendency to be careful when the case load of virus transmission rises. Our model incorporates the state of vaccination and the virus variants that form part of the transmission dynamics.

We also present the impact of lockdown policies and illustrate the advantage of adopting partial lockdown policies in the early period of 2022.


sentences:
Influence of meteorological factors and drought on coccidioidomycosis incidence in California, 2000-2020 BackgroundCoccidioidomycosis is an emerging infection in the southwestern United States. We examined the effects of precipitation and temperature on the incidence of coccidioidomycosis in California during 2000-2020, and estimated incident cases attributable to the California droughts of 2007-09 and 2012-15.

MethodsWe analyzed monthly California coccidioidomycosis surveillance data from 2000-2020 at the census tract-level using generalized additive models. Models included distributed lags of precipitation and temperature within each endemic county, pooled using fixed-effects meta-analysis. An ensemble prediction algorithm of incident cases per census tract was developed to estimate the impact of drought on expected cases.

ResultsAcross 14 counties examined, coccidioidomycosis was strongly suppressed during, and amplified following, the 2007-2009 and 2012-2015 droughts. An estimated excess of 1,358 and 2,461 drought-attributable cases were observed in California in the two years following the 2007-2009 and 2012-2015 droughts, respectively. These post-drought excess cases more than offset the drought-attributable declines of 1,126 and 2,192 cases, respectively, that occurred during the 2007-2009 and 2012-2015 droughts. Across counties, a temperature increase from the 25th to 75th percentile (interquartile range) in the summer was associated with a doubling of incidence in the following fall (incidence rate ratio (IRR): 2.02, 95% CI: 1.84, 2.22), and a one IQR increase in precipitation in the winter was associated with 1.45 (95% CI: 1.36, 1.55) times higher incidence in the fall. The effect of winter precipitation was stronger (interaction coefficient representing ratio of IRRs: 1.36, 95% CI: 1.25, 1.48) when preceded by two dry rather than average winters. Incidence in arid lower San Joaquin Valley counties was most sensitive to winter precipitation fluctuations, while incidence in wetter coastal counties was most sensitive to summer temperature fluctuations.

ConclusionsIn California, wet winters along with hot summers, particularly those following previous dry years, increased risk of coccidioidomycosis in California. Drought conditions may suppress incidence, then amplify incidence in subsequent years. With anticipated increasing frequency of drought in California, continued expansion of incidence, particularly in wetter, coastal regions, is expected.


sentences:
Effectiveness of the inactivated COVID-19 vaccine (CoronaVac) in adult population in Indonesia BackgroundInactivated SARS-CoV-2 vaccine has been included in the national COVID-19 vaccination program in Indonesia since January 2021. The study aims to assess the impacts of inactivated COVID-19 vaccine on infection, hospitalization, and death among adult population aged [≥]18 years in Bali, Indonesia.

MethodsTest-negative, case control study was conducted by linking SARS-CoV-2 laboratory records, vaccination, and health administrative data for the period of January 13 to June 30, 2021. Case-subjects were defined as individuals who had a positive RT-PCR test for SARS-CoV-2 during the period; they were matched with controls (tested negative) (1:1) based on age, sex, district of residence, and week of testing. We estimated the odds of vaccination in PCR confirmed, hospitalization and death due to COVID-19, accounting for the presence of comorbidities and prior infection. Vaccine effectiveness was estimated as (1-odds ratio) x 100%.

ResultsTotal 109,050 RT-PCR test results were retrieved during the January 13 to June 30, 2021. Of these, 14,168 subjects were eligible for inclusion in the study. Total 5518 matched case-control pairs were analyzed. Adjusted vaccine effectiveness (VE) against laboratory-confirmed SARS-CoV-2 infection was 14.5% (95% confidence interval -11 to 34.2) at 0-13 days after the first dose; 66.7% (95% CI: 58.1-73.5) at [≥]14 days after the second dose. The adjusted effectiveness against hospitalization and COVID-19-associated death was 71.1% (95% CI: 62.9-77.6) and 87.4% (95% CI: 65.1-95.4%) at [≥]14 days after receiving the second dose, respectively.

ConclusionsTwo-dose of inactivated CoronaVac vaccine showed high effectiveness against laboratory confirmed COVID-19 infection, hospitalization, and death associated with COVID-19 among adults aged [≥]18 years.


sentences: Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities: surveillance results from southern Sweden The risk of severe COVID-19 disease requiring hospitalization with extensive oxygen supply was compared among infected cases during two calendar periods when Delta and Omicron, respectively, were the dominating virus variants in Scania county, Sweden. Adjustments were made for differences among cases in comorbidities, prior infection, vaccination status, age and sex. Markedly lower risks were observed from Omicron among the vaccinated in the present study. The risk of severe disease was also lower for unvaccinated during Omicron than during Delta, but remained high among older people and middle-aged males with comorbidities. Efforts to increase vaccination uptake across countries, populations and subgroups should thus remain a public health priority.


sentences:
Equitable COVID-19 vaccine prioritization: front-line workers or 65-74 year olds? 1BackgroundThe COVID-19 epidemic in the United States has been characterized by two stark disparities. COVID-19 burden has been unequally distributed among racial and ethnic groups and at the same time the mortality rates have been sharply higher among older age groups.

These disparities have led some to suggest that higher equity could be attained by vaccinating front-line workers before vaccinating older individuals, who in the US are disproportionately Non-Hispanic White.

MethodsWe compare the performance of two distribution policies, one allocating vaccines to front-line workers and another to older individuals aged 65-74-year-old. We estimate both the number of lives saved and the number of years of life saved under each of the policies, overall and in every race/ethnicity groups, in the United States and every state.

FindingsWe show that prioritizing COVID-19 vaccines for 65-74-year-olds saves both more lives and more years of life than attributing vaccines front-line workers in each racial/ethnic group, in the United States as a whole and in nearly every state.

InterpretationWhen evaluating equity in vaccine allocation policies, the overall benefit to impact of each population subgroup should be considered, not only the proportion of doses that is distributed to each subgroup. Further work can identify prioritization schemes that perform better on multiple equity metrics.

FundingThe funding sources played no role in this research.


sentences: Evaluating binary classifiers: extending the Efficiency Index An "efficiency index" (EI) for the evaluation of binary classifiers was recently characterised, where EI is the ratio of classifier accuracy to inaccuracy. The purpose of this study was to further develop EI by substituting balanced accuracy and unbiased accuracy in place of accuracy, and their respective complements in place of inaccuracy, to construct balanced EI and unbiased EI measures. Additional investigations, using the dataset of a prospective pragmatic test accuracy study of a cognitive screening instrument, explored use of the log method to calculate confidence intervals for the various EI formulations; the dependence of EI formulations on prevalence; and comparison of EI formulations with analogous formulations based on the Identification Index (II), a previously described metric which is also based on accuracy and inaccuracy, where II is accuracy minus inaccuracy. EI formulations are shown to have advantages over II formulations, in particular their boundary values (0 and {infty}) mean that negative values never occur, unlike the case for II, and the inflection point of 1 demarcates likelihood of correct versus incorrect classification.

labels: neurology


sentences:
Corticospinal suppression underlying intact movement preparation fades in late Parkinson's disease In Parkinsons disease, neurophysiological abnormalities within the primary motor cortex have been shown to contribute to cardinal symptoms such as bradykinesia, but the exact modalities are still uncertain. Here, we propose that such impairment could involve alterations of mechanisms shaping motor activity specifically during voluntary movement preparation. Indeed, several past studies in healthy populations have suggested that a strong suppression of corticospinal excitability called "preparatory suppression" - propels movement execution by increasing motor neural gain. Thus, we hypothesized that a gradual alteration to this mechanism may contribute to progressive motor slowness in Parkinsons disease. We also predicted a benefit of dopamine medication in restoring correct motor neural activity during action preparation.

To test these hypotheses, we investigated preparatory suppression on two consecutive days in 29 Parkinsons disease patients (ON and OFF medication) and 29 matched healthy controls. Single-pulse transcranial magnetic stimulation was applied over both primary motor cortices, eliciting concurrent motor-evoked potentials in the two hands, while subjects were either at rest or prepared a left- or right-hand response in an instructed-delay choice reaction time task. Preparatory suppression was assessed by expressing the amplitude of motor potentials evoked during movement preparation relative to those obtained at rest. These neurophysiological measures were cross-analysed with task behaviour and clinical data.

Contrary to healthy controls, Parkinsons disease patients showed a lack of preparatory suppression, which appeared to depend on disease progression, but not on dopamine medication. Indeed, in relatively early disease stages, patients still exhibited partial preparatory suppression, while in later stages, they lacked it completely and even exhibited a tendency for corticospinal facilitation in the hand selected for movement execution. As expected, patients also showed increasing motor handicap with disease progression as well as a decreased movement velocity during the task, but such findings did not directly correlate with levels of preparatory suppression in our cohort. While dopamine medication had no effect on the latter, it did however globally reduce raw corticospinal excitability in the dominant hand.

Taken together, our results are in line with the idea that a lack of corticospinal suppression during movement preparation in Parkinsons disease slows down response execution and illustrate the importance of considering disease stages in such investigations; they also suggest differential roles of dopamine in shaping corticospinal output in those patients. Our findings thus support the use of task-related functional markers such as preparatory suppression in future studies on motor impairment in Parkinsons disease.


sentences:
Inference of causal relationships based on the genetics of cardiometabolic traits and conditions unique to females in >50,000 participants BackgroundCardiometabolic diseases are highly comorbid and associated with poor health outcomes. However, the investigation of the relationship between the genetic predisposition to cardiometabolic diseases with the risk of conditions unique to females such as breast cancer, endometriosis and pregnancy-related complications is highly understudied. This study aimed to estimate the cross-trait genetic overlap and influence of genetic burden of cardiometabolic traits on health conditions unique to females.

MethodsWe obtained data for female participants in the Penn Medicine BioBank (PMBB; 21,837 samples) and the electronic MEdical Records and GEnomics (eMERGE; 49,171 samples) network. We examined the relationship between four cardiometabolic phenotypes (body mass index (BMI), coronary artery disease (CAD), type 2 diabetes (T2D) and hypertension (through blood pressure measurements)) and 23 female health conditions by performing four analyses: 1) Cross-trait genetic correlation analyses to compare genetic architecture. 2) Polygenic risk scores (PRS)-based association tests to characterize shared genetic effects on disease risk. 3) Mendelian randomization (MR) for significant associations to assess cross-trait causal relationships. 4) Chronology analyses to visualize the timeline of events unique to groups of females with high and low genetic burden for cardiometabolic traits and highlight the disease prevalence in risk groups by age.

ResultsWe observed high genetic correlation among cardiometabolic and female health conditions. PRS meta-analysis identified 29 significant associations reflecting potential shared biology among common cardiometabolic phenotypes and female health conditions. Significant associations include PRSBMI with endometrial cancer and polycystic ovarian syndrome (PCOS), PRSCAD with breast cancer, and the PRST2D with gestational diabetes and PCOS. Mendelian randomization provided additional evidence of independent causal effects between T2D and gestational diabetes and CAD and with breast cancer. Our results reflected inverse association between PRSCAD and breast cancer. Lastly, as visualized from chronology analyses, individuals with high PRS are also more likely to develop conditions such as PCOS and gestational hypertension at earlier ages.

ConclusionsPolygenic susceptibility to cardiometabolic traits is associated with conditions unique to females. Several of these associations are likely to result from the complex pathophysiology of cardiometabolic risk, and others may reflect potential pleiotropic effects that go beyond cardiometabolic health in females.

labels: obstetrics and gynecology


sentences: The Macroscopic Growth Laws of Brain Metastases Tumor growth is the result of the interplay of complex biological processes in a huge number of individual cells in a changing environment. Effective simple mathematical laws have been shown to describe tumor growth in vitro, or in animal models with bounded-growth dynamics accurately. However, results for human cancers in patients are scarce. The study mined a dataset of 1133 brain metastases (BMs) with longitudinal imaging follow-up, treated with radiosurgery (SRS) to find growth laws for untreated BMs, relapsing treated BMs, and radiation necrosis (RN). Untreated BMs showed sustained growth acceleration, most likely related to the underlying evolutionary dynamics. Relapsing BM growth was slower, most probably due to a reduction in tumor heterogeneity after SRS, which may limit the evolutionary possibilities of the tumor. RN lesions had significantly larger growth exponents than relapsing BMs, providing a way to differentiate them from true progression. This may help in solving a problem of clinical relevance, since the first condition may resolve spontaneously, and not require further work-up, while the second requires therapeutic action.

labels: oncology


sentences:
DNA methylation-based age acceleration observed in IDH wild-type glioblastoma is associated with better outcome - including in elderly patients Elderly patients represent a growing proportion of individuals with glioblastoma, who however, are often excluded from clinical trials owing to poor expected prognosis. Little is known about molecular features that would justify different treatment modalities, not related to frailty and co-morbidities.

We investigated the DNA methylome (450k) for age related associations using 4 different glioblastoma datasets (mean age, years: DKFZ, 60; TCGA, 62; Nordic, 71; EORTC-26981/NCIC-CE.3 & Lausanne-Pilot, 54), including two are cohorts from clinical trials. We excluded patient samples not compatible with glioblastoma grade 4 WHO-CNS-5 classification 2021. The combined methylome was interrogated for differences based on age, DNA methylation (DNAm) age acceleration (DNAm age "Horvath-clock" minus patient age), methylation-based classification (Heidelberg), entropy, and functional methylation of DNA damage response (DDR) genes.

Age dependent methylation included 19 CpGs (p-value[≤]0.1, Bonferroni corrected), comprising ELOVL2 that is part of a 13-gene forensic age predictor. Three CpGs met our criteria of functional methylation defined as correlation of methylation with expression (r[≤]-0.3) of the corresponding gene. Most of the age related CpGs (n=16) were also associated with age acceleration that itself was associated with a large number of CpGs (n=50551). Over 70% age acceleration-associated CpGs (n=36348) overlapped with those associated with the methylation based tumor classification (n=170759). Functional methylation of few DDR genes was associated with age acceleration (n=8), tumor classification (n=12), or both (n=4), the latter including MGMT. DNAm age acceleration was significantly associated with better outcome in the trial cohorts of the EORTC/NCIC & Lausanne Pilot, and Nordic (treating elderly patients). Multivariate analysis included treatment (RT, RT/TMZ[->]TMZ; TMZ, RT), MGMT promoter methylation status, and interaction with treatment.

In conclusion, DNA methylation features of age acceleration are an integrative part of the methylation-based tumor classification (RTK I, RTK II, MES), while age seems hardly reflected in the glioblastoma DNA methylome.


sentences:
TEXT MINING OF THE PEOPLE's PHARMACY RADIO SHOW TRANSCRIPTS CAN IDENTIFY NOVEL DRUG REPURPOSING HYPOTHESES ObjectiveSocial media mining may provide surprising information about unknown effects of drugs. We endeavored to uncover such unknown drug-disease relationships by text mining of audio record transcripts from the popular NPR show, The Peoples Pharmacy.

Materials and MethodsWe used Google Cloud to transcribe episodes of the NPR podcast into textual documents. We then built a pipeline for systematically pre-processing the text to ensure quality input to the core classification model. Finally, results of the model were filtered by a series of post-processing steps. Our classification model itself uses the FLAIR language model pre-trained on PubMed abstracts. The modular nature of our pipeline allows for ease of future developments in this area by substituting higher quality components at each stage of the pipeline. To validate the drug-disease relating assertions extracted from the podcast, we utilized the DrugCentral database and ROBOKOP biomedical knowledge graph, which capture drug-disease relationships for FDA approved medications.

ResultsOur model identified 128 drug-disease pairs that were found in DrugCentral and 112 novel candidate pairs requiring expert review. To demonstrate the expert review process, we found literature evidence supporting the assertions for novel drug-disease pairs.

Discussion and ConclusionText mining of social media is increasingly used to uncover novel relationships between semantic concepts corresponding to biomedical concepts. However, mining audio transcripts of specialized podcast shows has not been explored previously for this purpose. Using this approach, we have identified several unknown drug-disease relationships with support in biomedical literature. The proposed approach can extend beyond radio podcasts and could be applied to any source of audio and textual data.

labels: health informatics


sentences:
Melanoma Skin Cancer Detection using Deep Learning Data from the World Health Organization (WHO) indicate a worldwide occurrence of 2 to 3 million cases of non-melanoma skin cancer annually. The American Cancer Society estimates that the incidence reaches 5.4 million in the United States alone. In cases of fatal diseases, early detection received great attention from the population and the media due to the premise that the earlier a cancer is identified, the greater the chances of cure. It is to be believed that the application of automated methods will help in early diagnosis, especially with the set of images with a variety of diagnoses. Thus, this article presents a system for recognizing dermatological diseases through images with lesions, a machine intervention in contrast to conventional detection based on medical personnel. Our model is designed in three phases, committing to data collection and augmentation, model development, and finally, prediction. We used various AI algorithms such as ANN with image processing tools to form a better structure, leading to higher accuracy of 89%.

Contactdheiver.santos@ictbridge.org, dheiver.santos@gmail.com


sentences: Using a Computational Cognitive Model to Simulate the Effects of Personal and Social Network Experiences on Seasonal Influenza Vaccination Decisions The substantial societal costs of seasonal influenza include illness, loss of lives, and loss of work productivity. Vaccination is the most effective means for averting the disease, yet fewer than half of adults in the United States are vaccinated annually. In this research, we focus on how personal experience and the experiences of close social contacts contribute to vaccination decisions. The results of a multi-year longitudinal survey study revealed the significant effects of personal and social network experiences on vaccination. We develop a memory-based model of vaccination decisions using the Adaptive Control of Thought - Rational (ACT-R) integrated cognitive architecture. The model accounts for the effects of personal and social experience on vaccination, and suggests interventions that may be effective in increasing vaccination uptake.

labels: health policy


sentences: OraSure InteliSwab Rapid Antigen Test performance with the SARS-CoV-2 Variants of Concern Alpha, Beta, Gamma, Delta, and Omicron The emergence of SARS-CoV-2 in the human population and the resulting COVID-19 pandemic has led to the development of various diagnostic tests. The OraSure InteliSwab(R) COVID-19 Rapid Test is a recently developed and FDA emergency use authorized rapid antigen-detecting test that functions as a lateral flow device targeting the nucleocapsid protein. Due to SARS-CoV-2 evolution, there is a need to evaluate the sensitivity of rapid antigen-detecting tests for new variants, especially variants of concern like Omicron. In this study, the sensitivity of the OraSure InteliSwab(R) Test was investigated using cultured strains of the known variants of concern (VOCs, Alpha, Beta, Gamma, Delta, and Omicron) and the ancestral lineage (lineage A). Based on dilution series in cell culture medium, an approximate limit of detection for each variant was determined. The OraSure InteliSwab(R) Test showed an overall comparable performance using recombinant nucleocapsid protein and different cultured variants with recorded limits of detection ranging between 3.77 x 105 and 9.13 x 105 RNA copies/mL. Finally, the sensitivity was evaluated using oropharyngeal swabs from Syrian golden hamsters inoculated with the 6 VOCs. Ultimately, the OraSure InteliSwab(R) COVID-19 Rapid Test showed no decrease in sensitivity between the ancestral SARS-CoV-2 strain and any VOCs including Omicron.


sentences:
Efficacy and safety of nitazoxanide combined with ritonavir-boosted atazanavir for the treatment of mild to moderate COVID-19 BackgroundFinding effective therapeutics for COVID-19 continues to be an urgent need, especially considering use context limitations and high cost of currently approved agents. The NACOVID trial investigated the efficacy and safety of repurposed antiprotozoal and antiretroviral drugs, nitazoxanide and atazanavir/ritonavir, used in combination for COVID-19.

MethodsIn this pilot, randomized, open-label trial conducted in Nigeria, patients diagnosed with mild to moderate COVID-19 were randomly assigned to receive standard of care (SoC) or SoC plus a 14-day course of nitazoxanide (1000 mg b.i.d.) and atazanavir/ritonavir (300/100 mg od) and followed through day 28. Study endpoints included time to clinical improvement, SARS-CoV-2 viral load change, and time to complete symptom resolution. Safety and pharmacokinetics of nitazoxanide active metabolite, tizoxanide, were also evaluated. This trial was registered with ClinicalTrials.gov (NCT04459286).

FindingsThere was no difference in time to clinical improvement between the SoC (n = 26) and SoC plus intervention arms (n = 31; Cox proportional hazards regression analysis adjusted hazard ratio, aHR = 0.898, 95% CI: 0.492-1.638, p = 0.725). No difference was observed in the pattern of saliva SARS-CoV-2 viral load changes from days 2 to 28 in the 35% of patients with detectable virus at baseline (20/57) between the two arms (aHR = 0.948, 95% CI: 0.341-2.636, p = 0.919). There was no significant difference in time from enrolment to complete symptom resolution (aHR = 0.535, 95% CI: 0.251 - 1.140, p = 0.105). Atazanavir/ritonavir increased tizoxanide plasma exposure by 68% and median trough plasma concentration was 1546 ng/ml (95% CI: 797-2557), above its putative EC90 in 54% of patients. Tizoxanide was not detectable in saliva.

InterpretationThese findings should be interpreted in the context of incomplete enrolment (64%) and the limited number of patients with detectable SARS-CoV-2 in saliva at baseline in this trial.

FundingThe University of Liverpool.

Research in contextO_ST_ABSEvidence before this studyC_ST_ABSThe potential efficacy of nitazoxanide as a repurposed drug for COVID-19 is being investigated in a number of studies due to confirmed in vitro activity against SARS-CoV-2. Available data from completed randomised controlled trials in which clinical improvement, effect on viral load, and symptom resolution were evaluated as outcomes do not offer conclusive evidence.

Added value of this studyIn the NACOVID trial, we sought to take advantage of a model-informed strategy and known interaction between nitazoxanide and atazanavir/ritonavir to achieve optimal concentration of tizoxanide in plasma, and possibly in respiratory tracts of patients with mild to moderate COVID-19. While this strategy significantly enhanced tizoxanide exposure in the plasma of patients, our data indicated poor penetration into the respiratory tracts. Specifically, there were no differences in time to clinical improvement, viral load changes, and symptom resolutions between patients who were given standard of care alone and those who combined it with study intervention.

Implications of all the available evidenceThe clinical benefit of nitazoxanide remains uncertain. The present study highlights the need for early insight into target site biodistribution of potential COVID-19 therapeutics to better inform candidate selection for clinical trials.


sentences:
Transparency and reporting characteristics of COVID-19 randomized controlled trials. Randomized controlled trials (RCTs) are essential to support clinical decision making. We assessed the transparency, completeness and consistency of reporting of 244 reports (120 peer-reviewed journal publications; 124 preprints) of RCTs assessing pharmacological interventions for the treatment of COVID-19 published the first 17 months of the pandemic (up to May 31, 2021). Transparency was poor. Only 55% of trials were prospectively registered; 39% made their full protocols available and 29% provided access to their statistical analysis plan. Only 6% completely reported the most important information. Primary outcome(s) reported in trial registries and published reports were inconsistent in 47% of trials. Of the 124 RCTs published as preprint, 76 were secondarily published in a peer-reviewed journal. There was no major improvement after the peer-review process.

Lack of transparency, completeness and consistency of reporting is an important barrier to trust, interpretation and synthesis in COVID-19 clinical trials.


sentences:
Alpha globin gene copy number and hypertension risk among Black Americans BACKGROUNDAlpha globin is expressed in the endothelial cells of human resistance arteries where it binds to endothelial nitric oxide synthase and limits release of the vasodilator nitric oxide. Genomic deletion of the alpha globin gene (HBA) is common among Black Americans and could lead to increased endothelial nitric oxide signaling and reduced risk of hypertension.

METHODSCommunity-dwelling US adults aged 45 years or older were enrolled and examined from 2003 to 2007, followed by telephone every 6 months, and reexamined from 2013 to 2016. At both visits, trained personnel performed standardized, in-home blood pressure measurements and pill bottle review. Prevalent hypertension was defined as systolic blood pressure [≥] 140mmHg or diastolic blood pressure [≥] 90mmHg or anti-hypertensive medication use. Droplet digital PCR was used to determine HBA copy number. The associations of HBA copy number with prevalent hypertension, resistant hypertension, and incident hypertension were estimated using multivariable regression.

RESULTSAmong 9,684 Black participants, 7,439 (77%) had hypertension at baseline and 1,044 of those had treatment-resistant hypertension. 1,000 participants were not hypertensive at baseline and participated in a follow up visit; 517 (52%) developed hypertension over median 9.2 years follow-up. Increased HBA copy number was not associated with prevalent hypertension (PR=1.00; 95%CI 0.98,1.02), resistant hypertension (PR=0.95; 95%CI 0.86,1.05), or incident hypertension (RR=0.96; 95%CI 0.86,1.07).

CONCLUSIONSThere were no associations between increased HBA copy number and risk of hypertension. These findings suggest that genetic variation in alpha globin gene expression does not modify the risk of hypertension among Black American adults.


sentences:
Comparative evaluation of oral lesions: Tale - the Covid 19 Tells Introduction & ObjectivesThe COVID-19 pandemic has been raging across the globe since early January 2020. India has reported over 27 million cases and more than 3, 00,000 deaths. This study was planned to analyze the differences in demographic, clinical features and oral manifestations of COVID 19 patients hospitalized during COVID-19 pandemic.

MethodsThis observational pilot study had total 36 participants, 12 each of mild, moderate and severe RT-PCR positive COVID cases hospitalized during COVID 19 pandemic. All demographic, clinical features, treatment details and oral manifestations were noted from first day of admission to hospital till treatment completion with follow up of minimum 7 days.

ResultsMean age of the patients was 39.44 {+/-}9.13 years with M: F ratio of 5:4. Most common clinical presentation was fever, shortness of breath and treatment involved was symptomatic with supplemental oxygen & mechanical ventilation. Most common oral site involved was tongue & oral lesions observed were herpes labialis, mucositis, burning sensation, dryness of oral cavity, angular chelitis, aphthous ulcers, geographic tongue, fissuring of tongue, candidiasis, coated tongue, sublingual varicosity, & scalloped tongue.

Interpretation and ConclusionAll demographic, clinical and oral manifestations were significantly different in mild, moderate and severe cases of covid hospitalized patients. Though clinical symptoms were improved, oral lesions were worsened. Oral Lesions seen in covid patients were associated with multiple drug therapy for illness along with poor oral hygiene, but further etiology for lesions needs to be evaluated. Sublingual varicosity was observed in our hospitalised covid patients, but large sample observation is required for confirmation of findings and may be an early oral feature for covid detection. Prevention is always better than cure, so all patients positive for Covid should have a full mouth examination. Oral health should be priority during overall management of COVID patients and dentists should be a part of Covid management team.

labels: dentistry and oral medicine


sentences:
Associations between prenatal exposure to maternal diabetes and child adiposity markers: mediating effects of brain structure ImportanceChildren prenatally exposed to maternal diabetes have a higher risk of developing obesity and metabolic disorders. Alterations in the brain development is hypothesized as a potential mechanism underlying this relationship but has not been fully tested in humans.

ObjectivesTo examine the mediating role of child brain structure in the relationships between prenatal exposure to maternal diabetes and child adiposity.

Design, setting and participantsThis was a cross-sectional study of children (ages 9-to-10-years-old) from the baseline assessment of the Adolescent Brain and Cognitive Development (ABCD) Study(R) (N=11,875).

ExposuresPrenatal exposure to maternal diabetes was determined via self-reported questionnaire.

Main outcomes and measuresChild adiposity markers included age- and sex-specific body mass index (BMI z-scores), waist circumference, and waist-to-height ratio (WHtR). T1-weighted magnetic resonance imaging (MRI) was used to assess brain structure. Linear mixed effects models examined associations of prenatal exposure to maternal diabetes with child adiposity markers and brain structure controlling for sociodemographic covariates. Mediation models were performed to investigate the mediating role of brain structure on the association between maternal diabetes exposure and child adiposity markers.

ResultsThe sample consisted of 8,521 children (agem: 9.92{+/-}0.63 years; sex: 51.4% males; 7% exposed to maternal diabetes). Children prenatally exposed vs. unexposed to maternal diabetes had greater BMI z-scores ({beta} (95% CI) = 0.175 (0.093, 0.256; FDR corrected P<0.001), waist circumference ({beta} (95% CI) = 0.201 (0.121, 0.281); FDR corrected P<0.001), WHtR ({beta} (95% CI) = 0.199 (0.119, 0.280); FDR corrected P<0.001). Prenatal exposure to maternal diabetes was associated with reduction in global ({beta} (95% CI) = -0.096 (-0.168, - 0.025); FDR corrected P=0.043) and regional cortical gray matter volume primarily in the frontal, temporal, and occipital areas. Whole-brain cortical gray matter volume partially mediated the association between prenatal exposure to maternal diabetes and WHtR (indirect path {beta} (95% CI) = 0.0027 (0.0002, 0.0067), P=0.034).

Conclusion and relevanceCortical gray matter volume partially mediated the link between prenatal exposure to maternal diabetes and WHtR. These results demonstrate a potential neurobiological mechanism by which prenatal exposure to maternal diabetes may be associated with increased risk for obesity and metabolic disorders in children.

Key Points

QuestionHow does prenatal exposure to maternal diabetes relate to brain structure, and does this relationship predict child adiposity markers.

FindingsCortical gray matter volume was reduced in children prenatally exposed to maternal diabetes; and it partially mediated the link between prenatal exposure to maternal diabetes and waist-to-height ratio in children.

MeaningThe association between prenatal exposure to maternal diabetes and increased risk for obesity and metabolic disorders in children may be driven in part by aberrant brain structure development.

labels: endocrinology


sentences:
Use of machine learning for comparing disease risk scores and propensity scores under complex confounding and large sample size scenarios: a simulation study BackgroundThe surge of treatments for COVID-19 in the ongoing pandemic presents an exemplar scenario with low prevalence of a given treatment and high outcome risk. Motivated by that, we conducted a simulation study for treatment effect estimation in such scenarios. We compared the performance of two methods for addressing confounding during the process of estimating treatment effects, namely disease risk scores (DRS) and propensity scores (PS) using different machine learning algorithms.

MethodsMonte Carlo simulated data with 25 different scenarios of treatment prevalence, outcome risk, data complexity, and sample size were created. PS and DRS matching with 1: 1 ratio were applied with logistic regression with least absolute shrinkage and selection operator (LASSO) regularization, multilayer perceptron (MLP), and eXtreme Gradient Boosting (XgBoost). Estimation performance was evaluated using relative bias and corresponding confidence intervals.

ResultsBias in treatment effect estimation increased with decreasing treatment prevalence regardless of matching method. DRS resulted in lower bias compared to PS when treatment prevalence was less than 10%, under strong confounding and nonlinear nonadditive data setting. However, DRS did not outperform PS under linear data setting and small sample size, even when the treatment prevalence was less than 10%. PS had a comparable or lower bias to DRS when treatment prevalence was common or high (10% - 50%). All three machine learning methods had similar performance, with LASSO and XgBoost yielding the lowest bias in some scenarios. Decreasing sample size or adding nonlinearity and non-additivity in data improved the performance of both PS and DRS.

ConclusionsUnder strong confounding with large sample size DRS reduced bias compared to PS in scenarios with low treatment prevalence (less than 10%), whilst PS was preferable for the study of treatments with prevalence greater than 10%, regardless of the outcome prevalence.

Key MessagesO_LIWhen handling nonlinear nonadditive data with strong confounding, DRS estimated by machine learning methods outperforms PS in scenarios with low treatment prevalence (less than 10%).
C_LIO_LIHowever, if having linear data and small sample size data with strong confounding, we did not observe DRS outperformed PS even when treatment prevalence was less than 10%.
C_LIO_LIOur results suggested that using PS performed better compared to DRS in tackling strong confounding problems with treatment prevalence greater than 10%.
C_LIO_LISmall sample size increased bias for both DRS and PS methods, and it affected DRS more than PS.
C_LI


sentences:
Serious hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants: an exposed-unexposed cohort study in December 2021 from the COVID-19 surveillance databases in France BackgroundA rapid increase in incidence of the SARS-CoV-2 Omicron variant occurred in France in December 2021, while the Delta variant was prevailing since July 2021. We aimed to determine whether the risk of a severe hospital event following symptomatic SARS-CoV-2 infection differs for Omicron versus Delta.

MethodsWe conducted a retrospective cohort study to compare severe hospital events (admission to intensive care unit or death) between Omicron and Delta symptomatic cases matched according to week of virological diagnosis and age. The analysis was adjusted for age, sex, vaccination status, presence of comorbidities and region of residence, using Cox proportional hazards model.

FindingsBetween 06/12/2021-28/01/2022, 184 364 cases were included, of which 931 had a severe hospital event (822 Delta, 109 Omicron). The risk of severe event was lower among Omicron versus Delta cases; the difference in severity between the two variants decreased with age (aHR=0{middle dot}11 95%CI: 0{middle dot}07-0{middle dot}17 among 40-64 years, aHR=0{middle dot}51 95%CI: 0{middle dot}26-1{middle dot}01 among 80+ years). The risk of severe event increased with the presence of comorbidities (for very-high-risk comorbidity, aHR=4{middle dot}18 95%CI: 2{middle dot}88-6{middle dot}06 among 40-64 years) and in males (aHR=2{middle dot}29 95%CI: 1{middle dot}83-2{middle dot}86 among 40-64 years) and was higher in unvaccinated compared to primo-vaccinated (aHR=6{middle dot}90 95%CI: 5{middle dot}26-9{middle dot}05 among 40-64 years). A booster dose reduced the risk of severe hospital event in 80+ years infected with Omicron (aHR=0{middle dot}27; 95%CI: 0{middle dot}11-0{middle dot}65).

InterpretationThis study confirms the lower severity of Omicron compared to Delta. However, the difference in disease severity is less marked in the elderly.


sentences: Pediatric Croup during the COVID-19 Omicron Variant Surge Croup is a common upper respiratory disease usually associated with parainfluenza virus, resulting in stridor, hoarse voice, barky cough, and variable respiratory distress. Here we examine the data at our center confirming a sharp increase in cases of croup associated with the Omicron variant. Data was retrospectively extracted from patient charts among those seen in the Emergency Department at Seattle Childrens Hospital. Inclusion criteria were patients who were assigned a diagnosis containing "croup" during either 5/30/2021-11/30/2021, a time period correlating with predominance of the COVID-19 Delta variant (B.1.617.2), or the initial phase of the Omicron variant surge (12/1/2021-1/15/2022). Contemporaneous publicly available local data on the proportion of SARS-CoV-2 samples in surrounding King County, Washington, with spike gene target failure on TaqPath PCR assays was used as a proxy for the proportion of infections caused by the Omicron variant. A total of 401 patients were diagnosed with croup during the Delta surge and 107 patients were diagnosed with croup during the Omicron surge. Patients who presented during the Omicron surge were more likely to test positive for COVID-19 (48.2% vs 2.8%, p < 0.0001). Children with a clinical diagnosis of croup during the Omicron surge were more likely to be prescribed racemic epinephrine as part of their care (21.5% vs 13.0%, p = 0.032). There were no differences in presenting age, rate of admission, rate of return to the ED within 72 hours, or admission among those who returned within 72 hours. During the Omicron surge, the incidence of croup nearly doubled compared to the rate in prior months, while at the same time the number of cases of parainfluenza virus identified decreased. Consistent with prior case reports, we have identified a sharp rise in cases of croup seen in our pediatric ED in parallel with the replacement of the SARS-CoV-2 Delta variant by Omicron as the dominant variant in our community.

labels: pediatrics


sentences:
Development of machine learning models for the prediction of complications after colonic, colorectal and small intestine anastomosis in psychiatric and non-psychiatric patient collectives (P-Study) Psychiatric and psychosomatic diseases are an increasingly cumbersome burden for the medical system. Indeed, hospital costs associated with mental health conditions have been constantly on the rise in recent years. Moreover, psychiatric conditions are likely to have a negative effect on the treatment of other medical conditions and surgical outcomes, in addition to their direct effects on the overall quality of life. Our study aims to investigate the impact of preoperative Risk factor, psychiatric and psychosomatic diseases on the outcomes of colorectal surgery and length of hospital stay via predictive modeling techniques.

MethodPatient data will be collected from several participating national and international surgical centers The machine learning models will be calculated and coded, but also published according to the TRIPOD guidelines (transparent reporting of a multivariable prediction model for individual prognosis or diagnosis).

ResultIt is conceivable to arrive at generalizable models predicting the abovementioned endpoints through large amounts of data from several centers. The models will be subsequently deployed as a free-to-use web-based prediction tool using the Shiny environment [47]. The cost for the hosting server and digital infrastructure will be covered by Dr. Anas Taha. The sponsor will store the data for ten years.

labels: surgery


sentences:
Vital signs as a source of racial bias AO_SCPLOWBSTRACTC_SCPLOWO_ST_ABSBackgroundC_ST_ABSracial bias has been shown to be present in clinical data, affecting patients unfairly based on their race, ethnicity and socio-economic status. This problem has the potential to be significantly exacerbated in the light of Artificial Intelligence-aided clinical decision making. We sought to investigate whether bias can be introduced from sources that are considered neutral with respect to ethnicity and race and consequently routinely used in modelling, specifically vital signs.

Methodsto perform our analysis, we extracted vital signs from 49,610 admissions from a cohort of adult patients during the first 24 hours after the admission to the Intensive Care Units (ICU), derived from multi-centre eICU-CRD database and single-centre MIMIC-III database, spanning over 208 hospitals and 335 ICUs. Using heart rate, SaO2, respiratory rate, systolic, diastolic, and mean blood pressure, we develop machine learning models based on Logistic Regression and eXtreme Gradient Boosting and investigate their performance in predicting patients self-reported race. To balance the dataset between the three ethno-races considered in our study, we use a matching cohort based on age, gender, and admission diagnosis.

Findingsstandard machine learning models, derived solely on six vital signs can be used to predict patients self-reported race with AUC of 75%. Our findings hold under diverse patient populations, derived from multiple hospitals and intensive care units. We also show that oxygen saturation is a highly predictive variable, even when measured through methods other than pulse oximetry, namely arterial blood gas analysis, suggesting that addressing bias in routinely collected clinical variables will be challenging.

Interpretationour finding that machine learning models can predict self-reported race using solely vital signs creates a significant risk in clinical decision making, further exacerbating racial inequalities, with highly challenging mitigation measures.

FundingThe funders had no role in the design of this study.

labels: medical ethics


sentences: Machine learning-based prediction of cognitive outcomes in de novo Parkinson's disease Cognitive impairment is a debilitating symptom in Parkinsons disease (PD). We aimed to establish an accurate multivariate machine learning (ML) model to predict cognitive outcome in newly diagnosed PD cases from the Parkinsons Progression Markers Initiative (PPMI). Annual cognitive assessments over an eight-year time span were used to define two cognitive outcomes of i) cognitive impairment, and ii) dementia conversion. Selected baseline variables were organized into three subsets of clinical, biofluid and genetic/epigenetic measures and tested using four different ML algorithms. Irrespective of the ML algorithm used, the models consisting of the clinical variables performed best and showed better prediction of cognitive impairment outcome over dementia conversion. We observed a marginal improvement in the prediction performance when clinical, biofluid, and epigenetic/genetic variables were all included in one model. Several cerebrospinal fluid measures and an epigenetic marker showed high predictive weighting in multiple models when included alongside clinical variables.


sentences:
Choice of Intraoperative Ultrasound adjuncts for Brain Tumor Surgery BackgroundGliomas are among the most typical brain tumors tackled by neurosurgeons. During navigation for surgery of glioma brain tumors, preoperatively acquired static images may not be accurate due to shifts. Surgeons use intraoperative imaging technologies (2-Dimensional and navigated 3 Dimensional ultrasound) to assess and guide resections. This paper aims to precisely capture the importance of preoperative parameters to decide which type of ultrasound to be used for a particular surgery.

MethodsThis paper proposes two bagging algorithms considering base classifier logistic regression and random forest. These algorithms are trained on different subsets of the original data set. The goodness of fit of Logistic regression-based bagging algorithms is established using hypothesis testing. Furthermore, the performance measures for random-forest-based bagging algorithms used are AUC under ROC and AUC under the precision-recall curve. We also present a composite model without compromising the explainability of the models.

ResultsThese models were trained on the data of 350 patients who have undergone brain surgery from 2015 to 2020. The hypothesis test shows that a single parameter is sufficient instead of all three dimensions related to the tumor (p < 0.05). We observed that the choice of intraoperative ultrasound depends on the surgeon making a choice, and years of experience of the surgeon could be a surrogate for this dependence.

ConclusionThis study suggests that neurosurgeons may not need to focus on a large set of preoperative parameters in order to decide on ultrasound. Moreover, it personalizes the use of a particular ultrasound option in surgery. This approach could potentially lead to better resource management and help healthcare institutions improve their decisions to make the surgery more effective.


sentences: COMPARATIVE PERFORMANCE OF TWO AUTOMATED MACHINE LEARNING PLATFORMS FOR COVID-19 DETECTION BY MALDI-TOF-MS The 2019 novel coronavirus infectious disease (COVID-19) pandemic has resulted in an unsustainable need for diagnostic tests. Currently, molecular tests are the accepted standard for the detection of SARS-CoV-2. Mass spectrometry (MS) enhanced by machine learning (ML) has recently been postulated to serve as a rapid, high-throughput, and low-cost alternative to molecular methods. Automated ML is a novel approach that could move mass spectrometry techniques beyond the confines of traditional laboratory settings. However, it remains unknown how different automated ML platforms perform for COVID-19 MS analysis. To this end, the goal of our study is to compare algorithms produced by two commercial automated ML platforms (Platforms A and B). Our study consisted of MS data derived from 361 subjects with molecular confirmation of COVID-19 status including SARS-CoV-2 variants. The top optimized ML model with respect to positive percent agreement (PPA) within Platforms A and B exhibited an accuracy of 94.9%, PPA of 100%, negative percent agreement (NPA) of 93%, and an accuracy of 91.8%, PPA of 100%, and NPA of 89%, respectively. These results illustrate the MS methods robustness against SARS-CoV-2 variants and highlight similarities and differences in automated ML platforms in producing optimal predictive algorithms for a given dataset.


sentences: Express yourself: Quantitative real-time PCR assays for rapid chromosomal antimicrobial resistance detection in Pseudomonas aeruginosa The rise of antimicrobial-resistant (AMR) bacteria is a global health emergency. One critical facet in tackling this epidemic is more rapid AMR diagnosis in serious multi-drug resistant pathogens like Pseudomonas aeruginosa. Here, we designed and then validated two multiplex quantitative real-time PCR (qPCR) assays to simultaneously detect differential expression of the resistance-nodulation-division efflux pumps MexAB-OprM, MexCD-OprJ, MexEF-OprN, MexXY-OprM, the AmpC {beta}-lactamase, and the porin OprD, which are commonly associated with chromosomally-encoded AMR. Next, qPCRs were tested on 15 sputa from 11 participants with P. aeruginosa respiratory infections to determine AMR profiles in vivo. We confirm multiplex qPCR testing feasibility directly on sputa, representing a key advancement in in vivo AMR diagnosis. Notably, comparison of sputa with their derived isolates grown in Luria-Bertani broth ({+/-}2.5% NaCl) or a 5-antibiotic cocktail showed marked expression differences, illustrating the difficulty in replicating in vivo expression profiles in vitro. Cystic fibrosis sputa showed significantly reduced mexE and mexY expression when compared with chronic obstructive pulmonary disease sputa, despite harbouring fluoroquinolone- and aminoglycoside-resistant strains, indicating that these loci are not contributing to AMR in vivo. oprD was also significantly downregulated in cystic fibrosis sputa, even in the absence of contemporaneous carbapenem use, suggesting a common adaptive trait in chronic infections that may affect carbapenem efficacy. Sputum ampC expression was highest in participants receiving carbapenems (6.7-15x), some of whom were simultaneously receiving cephalosporins, the latter of which would be rendered ineffective by the upregulated ampC. Our qPCR assays provide valuable insights into the P. aeruginosa resistome, and their use on clinical specimens will permit timely treatment alterations that will improve patient outcomes and antimicrobial stewardship measures.


sentences: Clustering analysis based on PiCCO parameters in patients with septic shock The current study identified three septic shock phenotypes according to the pulse index continuous cardiac output parameters: Phenotype-1: normal cardiac output and vascular resistance, high blood volume; Phenotype-2: low cardiac output, normal blood volume, and high vascular resistance. Phenotype-3: normal vascular resistance and blood volume, high cardiac output. The mortality was significantly high in phenotype-1, but comparable between phenotype-2 and phenotype-3 (13/17 (76.4) vs. 13/35 (37.1) vs. 16/46 (34.7), p <0.001). Compared to phenotype 1 and 3, phenotype 2 had a higher AKI incidence and higher creatinine level at discharge.


sentences:
Managing Endothelial Dysfunction in COVID-19: A Pilot, Double-Blind, Placebo-Controlled, Randomized Clinical Trial at the Lebanese American University Medical Center - Rizk Hospital (MEDIC-LAUMCRH) BackgroundCoronavirus disease 2019 (Covid-19) is associated with endothelial dysfunction. Pharmacologically targeting the different mechanisms of endothelial dysfunction may improve clinical outcomes and lead to reduced morbidity and mortality

MethodsIn this pilot, double-blind, placebo-controlled, randomized clinical trial we assigned patients who were admitted to the hospital with mild, moderate, or severe COVID-19 infection to receive, on top of optimal medical therapy, either an endothelial protocol consisting of (Nicorandil, L-arginine, Folate, Nebivolol, and Atorvastatin) or placebo for up to 14 days. The primary outcome was time to recovery, measured by an 8 category ordinal scale and defined by the time to being discharged from the hospital or hospitalized for infection-control or other nonmedical reasons. Secondary outcomes included the composite outcome of ICU admission or the need for mechanical ventilation, all-cause mortality, and the occurrence of side effects

ResultsOf 42 randomized patients, 37 were included in the primary analysis. The mean age of the patients was 57 years; the mean BMI of study participants was 29.14. History of hypertension was present in 27% of the patients, obesity in 45%, and Diabetes Mellitus in 21.6%. The median(Interquartile range) time to recovery was not significantly different between the endothelial protocol group (6 [4-12] days) and the placebo group (6 [5-8]days)(p-value = 0.854). Furthermore, there were no statistically significant differences in the need for mechanical ventilation or ICU admission, all-cause mortality, and the occurrence of side effects between the endothelial protocol group and the placebo group.

ConclusionAmong patients hospitalized with mild, moderate, or severe COVID-19 infection, targeting endothelial dysfunction by administering Nicorandil, L-arginine, Folate, Nebivolol, and Atorvastatin on top of optimal medical therapy did not decrease time to recovery. However, this treatment protocol was associated with an excellent safety profile. Adequately sized prospective randomized controlled trials are needed for the evaluation of the role of treating endothelial dysfunction in COVID-19 infection.

labels: cardiovascular medicine


sentences: Placental microRNAs associate with early childhood growth characteristics Poor placental function is a common cause of intrauterine growth restriction, which in turn is associated with increased risks of perinatal morbidity, mortality and long-term adverse health outcomes. Our prior work suggests that birthweight and childhood obesity-associated genetic variants functionally impact placental function and that placental microRNA are associated with birthweight. To address the influence of the placenta beyond birth, we assessed the relationship between placental microRNAs and early childhood growth. Using the SITAR package, we generated two parameters that describe individual weight trajectories of children (0-5 years) in the New Hampshire Birth Cohort Study (NHBCS). Using negative binomial generalized linear models, we identified placental microRNAs that associate with growth parameters (FDR<0.05), while accounting for sex, gestational age at birth, and maternal parity. Genes targeted by the six growth trajectory-associated microRNAs are enriched (FDR<0.02) in growth factor signaling (TGF/beta: miR-1290; EGF/R: miR-155, Let-7c; FGF/R: miR-155; IGF/R: Let-7c, miR-155, miR-1290), cyclic AMP signaling (miR-1246), calmodulin signaling (miR-216a, miR-1246), and NOTCH signaling (miR-629). These pathways function in placental proliferation, differentiation and function. Our results support the hypothesis that fetal environment, specifically placental cellular dynamics and function guided by microRNA expression, can have impacts beyond birth, into early childhood.


sentences:
Investigating the genetic pathways of insomnia in Autism Spectrum Disorder. BackgroundSleep problems are common in children with autism spectrum disorder (autism). There is sparse research to date to examine whether insomnia in people with autism is related to autism genetics or insomnia genetics. Moreover, there is a lack of research examining whether circadian-rhythm related genes share potential pathways with autism.

AimsTo address this research gap, we tested whether polygenic scores of insomnia or autism are related to risk of insomnia in people with autism, and to test whether the circadian genes are associated with insomnia in people with autism.

Methods and proceduresWe tested these questions using the phenotypically and genotypically rich MSSNG dataset (N=1,049) as well as incorporating in the analyses data from the Vanderbilt University Biobank (BioVU) (N=349).

Outcomes and resultsIn our meta-analyzed sample, there was no evidence of associations between the polygenic scores (PGS) for insomnia and a clinical diagnosis of insomnia, or between the PGS of autism and insomnia. We also did not find evidence of a greater burden of rare and disruptive variation in the melatonin and circadian genes in individuals with autism and insomnia compared to individuals with autism without insomnia.

Conclusions and implicationsOverall, we did not find evidence for strong effects of genetic scores influencing sleep in people with autism, however, we cannot rule out the possibility that smaller genetic effects may play a role in sleep problems. Our study indicated the need for a larger collection of data on sleep problems and sleep quality among people with autism.

labels: psychiatry and clinical psychology


sentences:
Working from home due to the COVID-19 pandemic abolished the sleep disturbance vulnerability of late chronotypes relieving their predisposition to depression Background and aimsEveningness is distinctively associated with sleep disturbances and depression symptoms due to the misalignment between biological and social clock. The widespread imposition of remote working due to the COVID-19 pandemic allowed a more flexible sleep schedule. This scenario could promote sleep and mental health of evening-type subjects. We investigated the effect of working from home on sleep quality/quantity and insomnia symptoms within the morningness-eveningness continuum, and its indirect repercussions on depressive symptomatology.

Methods610 Italian office workers (mean age {+/-} standard deviation, 35.47 {+/-} 10.17 yrs) and 265 remote workers (40.31 {+/-} 10.69 yrs) participated in a web-based survey during the second contagion wave of COVID-19 (28 November-11 December 2020). We evaluated chronotype, sleep quality/duration, insomnia, and depression symptoms through validated questionnaires. Three moderated mediation models were performed, testing the mediation effect of sleep variables on the association between morningness-eveningness continuum and depression symptoms, with working modality (office vs. remote working) as moderator of the relationship between chronotype and sleep variables.

ResultsRemote working led to delayed bedtime and get-up time. Working modality moderated the chronotype effect on sleep variables, as eveningness was related to worse sleep disturbances and shorter sleep duration only among the office workers. Working modality moderated the mediation of sleep variables between chronotype and depression. The above mediation vanished among remote workers.

ConclusionsRemote working strikingly abolished the vulnerability to sleep problems of evening-type subjects, relieving their predisposition to depressive symptomatology. A working environment complying with individual circadian preferences might ensure an adequate sleep quantity/quality to late chronotypes, promoting their mental health.

Statement of SignificanceThe present study is the first to evaluate the different effect of pandemic-related remote working on sleep health/habits depending on the chronotype. We found longer sleep duration and improved sleep disturbances among evening-type subjects when working from home. This outcome could be ascribable to a better alignment between the endogenous circadian phase and the working schedule, as remote workers reported later bedtimes and get-up times. Moreover, we showed how improved sleep weakened the susceptibility to depressive symptomatology of evening-type people, highlighting an intriguing implication of working remotely on mental health in this category. Morningness-eveningness predisposition should be considered when designing remote working policies, in order to promote sleep and mental health of late chronotypes during the pandemic emergency, as well as in the post-covid era.


sentences:
Coordinated Cortical Thickness Alterations across Psychiatric Conditions: A Transdiagnostic ENIGMA Study IntroductionMental disorders are increasingly conceptualized as overlapping spectra with underlying polygenicity, neurodevelopmental etiology, and clinical comorbidity. They share multi-level neurobiological alterations, including network-like brain structural alterations. However, whether alteration patterns covary across mental disorders in a biologically meaningful way is currently unknown.

MethodsWe accessed summary statistics on cortical thickness alterations from 12,024 patients with six mental disorders and 18,969 controls from the Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) consortium. First, we studied cortical thickness co-alteration networks as a form of pathological structural covariance. We identified regions exhibiting high inter-regional covariance across disorders ( hubs), and regions that strongly connect to these hubs facilitating network spreading of disease effects ( epicenters). Next, we applied manifold learning to reveal organizational gradients guiding transdiagnostic patterns of illness effects. Last, we tested whether these gradients capture differential cortical susceptibility with respect to normative cortical thickness covariance, cytoarchitectonic, transcriptomic, and meta-analytical task-based profiles.

ResultsCo-alteration network hubs were linked to normative connectome hubs and anchored to prefrontal and temporal disease epicenters. The principal gradient derived from manifold learning captured maximally different embedding of prefrontal and temporal epicenters within co-alteration networks, followed a normative cortical thickness gradient, and established a transcriptomic link to cortico-cerebello-thalamic circuits. Moreover, gradients segregated functional networks involved in basic sensory, attentional/perceptual, and domain-general cognitive processes, and distinguished between regional cytoarchitectonic profiles.

ConclusionTogether, our findings indicate that disease impact occurs in a synchronized fashion and along multiple levels of hierarchical cortical organization. Such axes can help to disentangle the different neurobiological pathways underlying mental illness.